MSK CME/X
Aug 2, 2025, 18:05
MSK Cancer Center CME: Expert Insights on Benign Hematology, Hemostasis and Thrombosis
MSK (Memorial Sloan Kettering Cancer Center) CME posted on X:
”Join us MSK Cancer Center for a state-of-the-art update in benign hematology, featuring expert-led discussions on complex hemostasis and thrombosis management, advances in hemolytic anemias, hematologic complications of cellular and immunotherapies, and emerging treatment strategies. Learn more here.”
Stay updated with Hemostasis Today.
-
May 9, 2026, 16:38Joseph R. Shaw: Risk Stratification is Only Useful if It is Practical, Consistent, and Easy to Apply at the Bedside
-
May 9, 2026, 16:11Milad Abdalla: When 180,000 Becomes 45,000 – The EDTA Trap
-
May 9, 2026, 16:10Gertrud U. Rey: Describing the Mechanism That Causes VITT
-
May 9, 2026, 16:09Dima Shulkin: The Earliest Warning Sign of a Severe Heart Attack May Already Be in the CBC
-
May 9, 2026, 16:08Luisanna M. Sánchez: Selected for the ASH Clinical Research Training Institute
-
May 9, 2026, 16:07Maha Othman: Key Highlights from Southern Ontario Reproductive Biology
-
May 9, 2026, 15:36Rami Z. Morsi: Advancing the Full Spectrum of Stroke Care at UCM 2026 3rd Annual Stroke Symposium
-
May 9, 2026, 15:34Recognizing the Essential Role of Psychosocial Care within Bleeding Disorders Care – EAHAD
-
May 9, 2026, 15:27Abdulrahman Nasiri: How AI and Deep Learning May Help Reshape the Future of Thalassaemia Care